Skip to content

Opening book details…

Can I read 2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 on EtoBox?

2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 by Mark G. Saulnier; David B. Frennesson; Mark D. Wittman; Kurt Zimmermann; Upender Velaparthi; David R. Langley; Charles Struzynski; Xiaopeng Sang; Joan Carboni; Aixin Li; Ann Greer; Zheng Yang; Praveen Balimane; Marco Gottardis; Ricardo Attar; Dolatrai Vyas is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is 2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 about?

A series of IGF-1R inhibitors is disclosed, wherein the (m-chlorophenyl)ethanol side chain of BMS-536924 (1) is replaced with a series of 2-(1H-imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chains. Some analogs show improved IGF-1R potency and oral exposure. Analogs from both series, 16a and 17f, show in vivo activity comparable to 1 in our constitutively activated IGF-1R Sal tumor model. This may be the due to the improved protein binding in human and mouse serum for imidazole 16a and the excellent oral exposure of pyrazole 17f.

Who reads 2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Mark G. Saulnier; David B. Frennesson; Mark D. Wittman; Kurt Zimmermann; Upender Velaparthi; David R. Langley; Charles Struzynski; Xiaopeng Sang; Joan Carboni; Aixin Li; Ann Greer; Zheng Yang; Praveen Balimane; Marco Gottardis; Ricardo Attar; Dolatrai Vyas
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0960-894X)
Published
2008
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)